Dr. Manos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
655 Euclid Ave Suite 309
Emergency Department
National City, CA 91950Phone+1 619-512-1166Fax+1 619-512-1161
Education & Training
Detroit Medical Center/Wayne State University (Detroit Receiving Hospital)Residency, Emergency Medicine, 1994 - 1997
Chicago College of Osteopathic Medicine at Midwestern UniversityClass of 1993
Certifications & Licensure
CA State License 1997 - 2026
MI State License 1994 - 1997
American Board of Emergency Medicine Emergency Medicine
Clinical Trials
- Study of Debio 1450 for Bacterial Skin Infections Start of enrollment: 2015 May 01
Publications & Presentations
PubMed
- 163 citationsSingle-Dose Oritavancin Versus 7–10 Days of Vancomycin in the Treatment of Gram-Positive Acute Bacterial Skin and Skin Structure Infections: The SOLO II Noninferiority...G. Ralph Corey, Samantha Good, Hai Jiang, Greg Moeck, Matthew A. Wikler
Clinical Infectious Diseases. 2015-01-15 - 81 citationsA randomized phase 2 study comparing two doses of delafloxacin with tigecycline in adults with complicated skin and skin-structure infectionsWilliam O'Riordan, Purvi Mehra, Paul Manos, Jeff Kingsley, Laura Lawrence
International Journal of Infectious Diseases. 2015-01-01 - 162 citationsFOCUS 1: A randomized, double-blinded, multicentre, phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumoniaThomas M. File, Donald E. Low, Paul B. Eckburg, George H. Talbot, H. David Friedland
The Journal of Antimicrobial Chemotherapy. 2011-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
